We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$281B
AUM Growth
-$2.86B
Cap. Flow
-$7.29B
Cap. Flow %
-2.6%
Top 10 Hldgs %
26.87%
Holding
10,979
New
1,821
Increased
3,804
Reduced
3,502
Closed
1,753

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.29B
2
NVDA icon
NVIDIA
NVDA
+$588M
3
BAC icon
Bank of America
BAC
+$289M
4
INTC icon
Intel
INTC
+$288M
5
UNP icon
Union Pacific
UNP
+$281M

Sector Composition

Rank Sector Weight
1 Technology 1.83%
2 Communication Services 1.58%
3 Consumer Discretionary 1.42%
4 Healthcare 0.84%
5 Financials 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APWC icon
9001
Asia Pacific Wire & Cable
APWC
$58.1M
$37K ﹤0.01%
+14,354
New +$38K
CDMO
9002
PUT
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$37K ﹤0.01%
12,500
+400
+3% +$1.24K
VIRX
9003
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$37K ﹤0.01%
386
-25
-6% -$4.29K
APOPW
9004
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$37K ﹤0.01%
19,708
-8,865
-31% -$20.1K
BDRX
9005
Biodexa Pharmaceuticals
BDRX
$1.01M
0
CRIS icon
9006
CALL
Curis
CRIS
$3.73M
$36K ﹤0.01%
+28
New +$36.7K
NCTY
9007
The9 Ltd
NCTY
$74.1M
$36K ﹤0.01%
+251
New +$57K
SSKN
9008
DELISTED
Strata Skin Sciences
SSKN
$36K ﹤0.01%
+3,224
New +$43K
AHPI
9009
DELISTED
Allied Healthcare Products
AHPI
$36K ﹤0.01%
+12,655
New +$33.1K
STAB
9010
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$36K ﹤0.01%
+11,987
New +$42.3K
CDTI
9011
DELISTED
CDTI Advanced Materials, Inc. Common Stock
CDTI
$36K ﹤0.01%
7,485
+4,500
+151% +$29.6K
ANTH
9012
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$36K ﹤0.01%
112,400
-24,000
-18% -$35.8K
PTX
9013
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$36K ﹤0.01%
15,124
-18,618
-55% -$47K
NM
9014
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
$35K ﹤0.01%
3,860
-10
-0.3% -$124
ISEE
9015
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$35K ﹤0.01%
12,600
-3,000
-19% -$8.7K
WMGIZ
9016
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$35K ﹤0.01%
26,333
+4,602
+21% +$6.6K
CLIRW
9017
DELISTED
ClearSign Combustion Corporation Warrant
CLIRW
$35K ﹤0.01%
138,943
-373
-0.3% -$309
ACHV icon
9018
Achieve Life Sciences
ACHV
$851M
$34K ﹤0.01%
133
+76
+133% +$21.7K
GIGM icon
9019
CALL
GigaMedia
GIGM
$15.8M
$34K ﹤0.01%
+12,100
New +$37.7K
QUIK icon
9020
PUT
QuickLogic
QUIK
$204M
$34K ﹤0.01%
1,579
+329
+26% +$8.31K
CNET icon
9021
PUT
ZW Data Action Technologies
CNET
$5.25M
$33K ﹤0.01%
+1,005
New +$63.2K
PMTS icon
9022
CPI Card Group
PMTS
$328M
$33K ﹤0.01%
+10,876
New +$33K
OIIM
9023
DELISTED
02Micro International
OIIM
$33K ﹤0.01%
24,500
-10,408
-30% -$15.7K
ASNA
9024
DELISTED
Ascena Retail Group, Inc.
ASNA
$33K ﹤0.01%
810
-2,854
-78% -$121K
INOD icon
9025
Innodata
INOD
$1.92B
$32K ﹤0.01%
+29,209
New +$34K

Similar funds

Jeff Yass's Q1 2018 Portfolio in Review

As of Q1 2018, Jeff Yass held 10,979 positions worth $281B, down 1% from $283B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q1 2018 filing shows 1,821 new, 3,804 increased, 3,502 reduced and 1,753 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M. The largest sale was Apple, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, down from 2.6% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Jeff Yass's largest Q1 2018 buy was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M.
  • Jeff Yass added most to Meta Platforms (Facebook) in Q1 2018, an estimated $944M increase.
  • Jeff Yass's biggest Q1 2018 reduction was Apple, cutting an estimated $1.29B.
  • Jeff Yass fully exited iShares MSCI Japan ETF in Q1 2018, selling an estimated $84.1M.
  • Jeff Yass's ten largest holdings make up 27% of its $281B portfolio in Q1 2018.
  • Jeff Yass opened 1,821 new positions and closed 1,753 in Q1 2018.
  • Jeff Yass's portfolio value fell 1% quarter-over-quarter to $281B.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.